This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stock Market, Feb. 28: What's on Tap

Stocks in this article: MATK

NEW YORK ( TheStreet -- Civil war in Libya has caused oil prices to skyrocket during the past week as traders attempted to lock in prices with two million barrels of daily production expected to be removed from the market.

The stock market pulled back as a result, although the S&P 500 is still up 4% so far in 2011. The energy sector has been the leader, logging gains of 12%. When Wall Street reconvenes Monday, Libya's turmoil will remain front and center.

On the economic front, personal income and personal spending are due out at 8:30 a.m. EST. This is a quick read on the true strength of the consumer. How much is coming into the house and how much is going out. A good consumption number usually boosts the market because it means people are spending and not saving. As a side note -- Americans are still spending roughly 95 cents out of each new dollar.

Chicago PMI arrives at 9:45 a.m. EST followed by Pending Home Sales at 10 a.m. EST. Last week's strong existing homes sales reflected banks dumping foreclosed homes on the market and getting rid of that backlog. So the headline number could be good but look closely at the details. Is it more foreclosed homes accounting for all the sales action?

Ultimately, traders are just biding time until the end of the week for the unemployment report. This is the one they are waiting for. The big kahuna.

There are several companies reporting their quarterly results tomorrow, but none are really market movers. Among the names due Monday are Bluefly (BFLY), the internet retailer; Coeur d'Alene Mines (CDE - Get Report), which might be of interest since gold and silver have been skyrocketing; Rosetta Stone (RST - Get Report), which issued a warning earlier this month; and Martek Biosciences (MATK), which has seen a lot of insider buying of late and could be worth watching. Healthy insider buying is always a good sign.

Also this week, the Committee on Financial Services is set to begin marking up bills designed to terminate ineffective housing foreclosure programs. What? Weren't they were all so successful? The programs were a huge waste of taxpayer money and delayed banks the ability to get non-performing loans off of their books quickly. Good riddance.

-- Written by Debra Borchardt in New York.



>To contact the writer of this article, click here: Debra Borchardt.

>To follow the writer on Twitter, go to http://twitter.com/wallandbroad.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs